Scott D. Cramer

4.5k citations

72 papers · 3.3k indexed · h-index 35

Impact in

Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment

Papers in ⓘ

Pulmonary and Respiratory Medicine 35
- Prostate Cancer Treatment and Research 25
- Prostate Cancer Diagnosis and Treatment 9
- Kidney Stones and Urolithiasis Treatments 6
Cancer Research 11

Co-authors: Donna M. Peehl (8 shared papers)Wendy W. Barclay (6 shared papers)Ralph D. Woodruff (3 shared papers)Jianfeng Xu (7 shared papers)Lina Romero (10 shared papers)Guangchao Sui (7 shared papers)Andrew Thorburn (4 shared papers)Zuxiong Chen (2 shared papers)
Journals: The Prostate (6 papers)Endocrinology (6 papers)Cancer Research (5 papers)Molecular Cancer Research (4 papers)The Journal of Urology (3 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Scott D. Cramer

70 papers receiving 3.2k citations

Peers

Countries citing papers authored by Scott D. Cramer

Since Specialization

Citations

This map shows the geographic impact of Scott D. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Cramer more than expected).

Fields of papers citing papers by Scott D. Cramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Cramer. The network helps show where Scott D. Cramer may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott D. Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott D. Cramer Line = papers co-authored together Scott D. Cramer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis Developmental Cell ·Megan L. Goodall, Brent E. Fitzwalter, Shadi Zahedi, Min Wu, Diego A. Rodríguez, Jean M. Mulcahy Levy, Douglas R. Green, Michael J. Morgan, Scott D. Cramer, Andrew Thorburn	2016	254
2	Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer Molecular Cancer Therapeutics ·Isabel R. Schlaepfer, Leah Rider, Lindsey Ulkus Rodrigues, Miguel A. Gijón, Colton T. Pac, Lina Romero, Adela Cimic, S. Joseph Sirintrapun, L. Michael Glodé, Robert H. Eckel, Scott D. Cramer	2014	249
3	MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β Molecular Cancer ·Paul D. Cao, Zhiyong Deng, Meimei Wan, Weiwei Huang, Scott D. Cramer, Jianfeng Xu, Ming Lei, Guangchao Sui	2010	203
4	Prostate Specific Antigen Cleaves Parathyroid Hormone-Related Protein in the PTH-like Domain: Inactivation of PTHrP-Stimulated cAMP Accumulation in Mouse Osteoblasts The Journal of Urology ·Scott D. Cramer, Zuxiong Chen, Donna M. Peehl	1996	154
5	The *ADPRT V762A* Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function Cancer Research ·Kristin L. Lockett, M. Craig Hall, Jianfeng Xu, S. Lilly Zheng, Marianne Berwick, Shu‐Chun Chuang, Peter E. Clark, Scott D. Cramer, Kurt Lohman, Jennifer J. Hu	2004	145
6	25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. PubMed ·Andrea M. Barreto, Gary G. Schwartz, Ralph D. Woodruff, Scott D. Cramer	2000	110
7	Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses Virology ·Maryam Ahmed, Scott D. Cramer, Douglas S. Lyles	2004	106
8	Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature Lab on a Chip ·Alireza Salmanzadeh, Lina Romero, Hadi Shafiee, Roberto C. Gallo‐Villanueva, Mark A. Stremler, Scott D. Cramer, Rafael V. Davalos	2011	103
9	Selective Inactivation of a Fas-associated Death Domain Protein (FADD)-dependent Apoptosis and Autophagy Pathway in Immortal Epithelial Cells Molecular Biology of the Cell ·Jacqueline Thorburn, Franklin Moore, Anuradha Rao, Wendy W. Barclay, Lance R. Thomas, Ken Grant, Scott D. Cramer, Andrew Thorburn	2005	93
10	A System for Studying Epithelial-Stromal Interactions Reveals Distinct Inductive Abilities of Stromal Cells from Benign Prostatic Hyperplasia and Prostate Cancer Endocrinology ·Wendy W. Barclay, Ralph D. Woodruff, M. Craig Hall, Scott D. Cramer	2004	88
11	Glycolate and glyoxylate metabolism in HepG2 cells American Journal of Physiology-Cell Physiology ·Paul R.S. Baker, Scott D. Cramer, Martha Kennedy, Dean G. Assimos, Ross P. Holmes	2004	86
12	Genetic markers associated with early cancer‐specific mortality following prostatectomy Cancer ·Wennuan Liu, Chunmei Xie, Christopher Y. Thomas, Seong‐Tae Kim, Johan Lindberg, Lars Egevad, Zhong Wang, Zheng Zhang, Jishan Sun, Jielin Sun, Patrick P. Koty, A. Karim Kader, Scott D. Cramer, G. Steven Bova, S. Lilly Zheng, Henrik Grönberg, William B. Isaacs, Jianfeng Xu	2013	71
13	Preferential production of latent transforming growth factor β‐2 by primary prostatic epithelial cells and its activation by prostate‐specific antigen Journal of Cellular Physiology ·Sarah L. Dallas, Shujun Zhao, Scott D. Cramer, Z. Chen, D M Peehl, Lynda F. Bonewald	2004	70
14	Association Between Genetic Polymorphisms in the Prostate-Specific Antigen Gene Promoter and Serum Prostate-Specific Antigen Levels JNCI Journal of the National Cancer Institute ·Scott D. Cramer, Bao Chang, Anuradha Rao, Gregory A. Hawkins, Shun Zheng, Wendy Wade, R. T. Cooke, Lora N. Thomas, Eugene R. Bleecker, W. J. Catalona, D. A. Sterling, Deborah A. Meyers, Jill Ohar, Jianfeng Xu	2003	70
15	Yin Yang 1 regulates the transcriptional activity of androgen receptor Oncogene ·Zhen Deng, Mei Wan, Peng Cao, Anuradha Rao, Scott D. Cramer, Guangchao Sui	2009	62
16	Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer Cancer Research ·Lindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, Lina Romero, Anis Karimpour‐Fard, Massimo Loda, M. Scott Lucia, Min Wu, Lihong Shi, Adela Cimic, S. Joseph Sirintrapun, Rosalie Nolley, Colton T. Pac, Haitao Chen, Donna M. Peehl, Jianfeng Xu, Wennuan Liu, James C. Costello, Scott D. Cramer	2015	59
17	5-Oxo-ETE analogs and the proliferation of cancer cells Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Joseph T. O’Flaherty, LeAnn C. Rogers, Christian M. Paumi, Roy R. Hantgan, Lance R. Thomas, Carl E. Clay, Kevin P. High, Yong Q. Chen, Mark C. Willingham, Pamela K. Smitherman, Timothy E. Kute, Anuradha Rao, Scott D. Cramer, Charles S. Morrow	2005	55
18	Genistein and Vitamin D Synergistically Inhibit Human Prostatic Epithelial Cell Growth Journal of Nutrition ·Anuradha Rao, Ralph D. Woodruff, Wendy Wade, Timothy E. Kute, Scott D. Cramer	2002	55
19	Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[18F]Fluoro-d-Glucose Uptake in Prostate Cancer Mouse Xenografts Molecular Imaging and Biology ·Isabel R. Schlaepfer, L. Michael Glodé, Carolyn A. Hitz, Colton T. Pac, Kristen E. Boyle, Paul Maroni, Gagan Deep, Rajesh Agarwal, Scott Lucia, Scott D. Cramer, Natalie J. Serkova, Robert H. Eckel	2015	53
20	Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells Cancer Research ·Anuradha Rao, April Coan, JoEllen Welsh, Wendy W. Barclay, Constantinos Koumenis, Scott D. Cramer	2004	53

About Scott D. Cramer

Scott D. Cramer is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Oncology, having authored 72 papers that have together received 3.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Vitamin D Research Studies (9 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Sexual Differentiation and Disorders (6 papers), Estrogen and related hormone effects (6 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Bone health and treatments (6 papers). The work is most often cited by research in Cancer Research (788 citations), Pulmonary and Respiratory Medicine (924 citations), Oncology (677 citations), Pathology and Forensic Medicine (439 citations) and Molecular Biology (1.6k citations). Scott D. Cramer has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Donna M. Peehl, Wendy W. Barclay, Ralph D. Woodruff, Jianfeng Xu, Lina Romero, Guangchao Sui, Andrew Thorburn, Zuxiong Chen, Anuradha Rao and M. Craig Hall. Their work appears in journals such as The Prostate, Endocrinology, Cancer Research, Molecular Cancer Research and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact